More Content

PM+: Consistency needed for EU clinical trials regulation to work

28 May 2015

The EU's new clinical trials regulation still has a few implementation challenges to overcome, says Prof. Christian Dittrich.

PM+: One-time consent on data protection rules a 'necessity' for European health research

13 March 2015

The risk of potentially damaging consequences to Europe's health research if EU policymakers don't get Europe's data protection rules right is clear, argues John Crown.

ESMO: Pancreatic Cancer: A Guide for Patients

13 November 2014

Guides for Patients are designed to assist patients, their relatives and caregivers to better understand the nature of different types of cancer and...

RCE: EMA open to discuss use of complementary methodologies for rare cancers

15 October 2014

RCE argue that a higher degree of uncertainty should be accepted for regulatory as well as clinically informed decision-making in rare cancers...

ESMO: Discrepancies in Access to New Cancer Drugs Revealed

13 October 2014

Canada and Europe sometimes years slower than USA in approving cancer drugs. Breast cancer patients in Eastern Europe have inadequate access to ...

ESMO: Many Patients Lack Information About the Use of Targeted Therapies

10 October 2014

More than three quarters of oncology specialists in Europe, South America and Asia believe their patients are not always well enough informed about...

ESMO: Eastern Europe Lacks Advanced Cancer Treatment

9 October 2014

Treatments for advanced cancer are often unavailable or available only at substantial out of pocket cost in many Eastern European countries compared...